{
    "2020-02-28": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Provides Update from Phase 3 Study Evaluating VENCLEXTAÂ® (venetoclax) in Combination with Low-Dose Cytarabine in Newly-Diagnosed Patients with Acute Myeloid Leukemia (AML)",
                "features": {
                    "keywords": [
                        "Phase 3 Study",
                        "VENCLEXTA",
                        "venetoclax",
                        "Low-Dose Cytarabine",
                        "Acute Myeloid Leukemia",
                        "AML"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "FORM 8.3 - ABBVIE PLC",
                "features": {
                    "keywords": [
                        "FORM 8.3",
                        "ABBVIE PLC"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "regulatory"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Stock Falls 3%",
                "features": {
                    "keywords": [
                        "Stock Falls",
                        "3%"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "FORM 8.3 - ABBVIE INC - Amendment",
                "features": {
                    "keywords": [
                        "FORM 8.3",
                        "ABBVIE INC",
                        "Amendment"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "regulatory"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}